Share chart Paion AG
Extended chart
Simple chart
About Paion AG
Paion AG, a specialty pharmaceutical company, develops and commercializes drugs for hospital-based sedation, anesthesia, and intensive care medicine services worldwide. The company's lead product is Remimazolam, an ultra-short-acting intravenous benzodiazepine sedative/anesthetic, which is in clinical development for use in procedural sedation, general anesthesia, and intensive care unit sedation. more details| Industry | Pharmaceuticals |
|---|---|
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | eur |
| Сайт | https://www.paion.com |
| Цена ао | 0.02 |
| Change price per day: | 0% (0.02) |
|---|---|
| Change price per week: | 0% (0.02) |
| Change price per month: | 0% (0.02) |
| Change price per 3 month: | 0% (0.02) |
| Change price per half year: | 0% (0.02) |
| Change price per year: | -20.32% (0.0251) |
| Change price per 3 year: | -99.2% (2.5054) |
| Change price per year to date: | 0% (0.02) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| College Retirement Equities Fund-Stock Account | 20390 | 0.29 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Sebastian Werner | Member of Management Board & CFO | 238.24k | |
| Mr. Tilmann Bur | Member of Management Board | N/A | 1965 (60 years) |
| Ralf Penner | Vice President of Investor Relations & Public Relations | N/A | |
| Dr. Thomas Stoehr | Senior Vice President of Development | N/A | |
| Mr. Gregor Siebert | Chairman of Management Board & CEO |
Address: Germany, Aachen, Heussstrasse 25 - open in Google maps, open in Yandex maps
Website: https://www.paion.com
Website: https://www.paion.com
